Digital Polymerase Chain Reaction (PCR), especially Droplet Digital PCR (ddPCR) technology developed by Bio-Rad, has revolutionized the landscape of nucleic acid quantification, offering unmatched precision, sensitivity, and absolute quantification of nucleic acids. This third generation of PCR
Roche is considering seeking accelerated approval for its experimental Alzheimer’s drug, trontinemab, following promising early results. Trontinemab is currently in Phase 2 testing and has shown significant potential in reducing amyloid levels in the brain. This approach has been previously
Novo Nordisk recently announced its intention to seek regulatory approval for the use of semaglutide, the active ingredient in its profitable weight loss drug, for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). This decision came after a Phase 3 clinical trial yielded
In a landmark event for Denmark’s technology landscape, the nation's first AI supercomputer, Gefion, has been officially inaugurated. This momentous occasion promises to expedite drug discovery and address a variety of societal challenges. The Novo Nordisk Foundation, a principal player in the
In a significant development, Monte Rosa Therapeutics, a biotechnology company based in Boston, has finalized a highly lucrative global exclusive development and commercialization license agreement with Novartis valued at up to $2.1 billion on October 28, 2024. Monte Rosa Therapeutics is focused on
MilliporeSigma, a prominent player in the life sciences sector, has launched a transformative $76 million investment dedicated to expanding its ADC (antibody-drug conjugates) manufacturing capabilities at its St. Louis, Missouri facility. This monumental investment encapsulates the extensive
